To the annual general meeting (AGM) of ADDvise Group AB (publ) on 5 May 2023, the nomination committee has decided to propose re-election of Fredrik Celsing, Staffan Torstensson, Erland Pontusson, Johanne Brændgaard and Anna Ljung as members of the board of directors. It is proposed that Staffan Torstensson is re-elected chairman of the board of directors.
A presentation of the current members of the board of directors is available on ADDvise Group’s website.
The nomination committee's full proposals to the AGM 2023 will be published in connection with the notice to the AGM 2023.
The nomination committee of ADDvise Group for the AGM 2023 consists of:
The members of the nomination committee jointly represent approximately 35 percent of the votes in the company as per June 30, 2022.
For further information, please contact:
Hanna Myhrman, General Counsel
+46 709 – 82 92 23
hanna.myhrman@addvisegroup.se
About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.
